These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32822127)
21. MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score. Pausch AM; Elsner C; Rupp NJ; Eberli D; Hötker AM Eur J Radiol; 2024 Jun; 175():111463. PubMed ID: 38615502 [TBL] [Abstract][Full Text] [Related]
22. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer? Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783 [TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial. Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431 [TBL] [Abstract][Full Text] [Related]
24. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One]. Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710 [TBL] [Abstract][Full Text] [Related]
25. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy. Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233 [TBL] [Abstract][Full Text] [Related]
27. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans. Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990 [TBL] [Abstract][Full Text] [Related]
28. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. Stabile A; Orczyk C; Hosking-Jervis F; Giganti F; Arya M; Hindley RG; Dickinson L; Allen C; Punwani S; Jameson C; Freeman A; McCartan N; Montorsi F; Briganti A; Ahmed HU; Emberton M; Moore CM BJU Int; 2019 Sep; 124(3):431-440. PubMed ID: 30753756 [TBL] [Abstract][Full Text] [Related]
29. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839 [TBL] [Abstract][Full Text] [Related]
30. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy. Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112 [TBL] [Abstract][Full Text] [Related]
31. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851 [TBL] [Abstract][Full Text] [Related]
33. Follow-Up of Men Who Have Undergone Focal Therapy for Prostate Cancer with HIFU-A Real-World Experience. Mala KS; Plage H; Mödl L; Hofbauer S; Friedersdorff F; Schostak M; Miller K; Schlomm T; Cash H J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002699 [TBL] [Abstract][Full Text] [Related]
34. High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform. Yee CH; Chiu PK; Teoh JY; Ng CF; Chan CK; Hou SM Adv Urol; 2021; 2021():7157973. PubMed ID: 34950204 [TBL] [Abstract][Full Text] [Related]
35. Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom. Johnston MJ; Emara A; Noureldin M; Bott S; Hindley RG Urology; 2019 Nov; 133():175-181. PubMed ID: 31449831 [TBL] [Abstract][Full Text] [Related]
36. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation. Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671 [TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study. Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940 [TBL] [Abstract][Full Text] [Related]
38. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI. Connor MJ; Gorin MA; Ahmed HU; Nigam R Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):232-243. PubMed ID: 32051551 [TBL] [Abstract][Full Text] [Related]
39. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Ghai S; Finelli A; Corr K; Chan R; Jokhu S; Li X; McCluskey S; Konukhova A; Hlasny E; van der Kwast TH; Incze PF; Zlotta AR; Hamilton RJ; Haider MA; Kucharczyk W; Perlis N Radiology; 2021 Mar; 298(3):695-703. PubMed ID: 33529137 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry. Lovegrove CE; Peters M; Guillaumier S; Arya M; Afzal N; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Virdi J; Winkler M; Emberton M; Ahmed HU; Shah TT; Minhas S BJU Int; 2020 Jun; 125(6):853-860. PubMed ID: 31971335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]